JPRN-UMIN000014383已完成未知
A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease - A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease
ABC Tx group0 个研究点目标入组 80 人开始时间: 2014年6月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10years-old 至 16years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with thyrotoxic crisis 2)Patients who receive pharmacotherapy for diabetes, hepatic and renal disease 3)Medical history of Graves disease. Patients who have already used cholesterol absorption inhibitor. 4)Use of coumarin anticoagulants, digitalis, and bile acids preparations 5)Judged inappropriate for this study by the physicians.
研究者
相似试验
尚未招募
不适用
A randomized controlled study of a combination of internal and external treatments for albumin paclitaxel-related peripheral neurotoxicityPeripheral neurotoxicity due to albumin paclitaxelITMCTR2200006029Shanxi Institute of Traditional Chinese Medicine
尚未招募
4 期
A Randomized Controlled Study on the Combined and Sequential Optimal Plan of Traditional Chinese Medicine Internal and External Therapy for PsoriasisPsoriasisITMCTR2000003594Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
已完成
不适用
A prospective, randomized controlled study to compare clinical outcomes between bortezomib-melphalan-prednisolone and lenaldomide-dexamethasone in patients with transplant-ineligible, newly diagnosed multiple myelomaNeoplasmsKCT0005006The Catholic University of Korea, Seoul St. Mary's Hospital552
已完成
不适用
comparison of two different airwaysCTRI/2021/10/037601School of Medical Sciences and Research Sharda University100
未知
3 期
Randomized controlled trial of the combination of exercise therapy and BCAA supplementation for chronic liver diseaseschronic liver diseaseJPRN-UMIN000001893Tohoku University40